Our innovative approach
For more than 50 years, blood pressure, diabetes, and cholesterol have been used as prevention parameters for cardiovascular disease. However, only 50% of individuals with hypertension are treated, and 50% of these are not on target. Mercury is no longer permitted, and electronic devices are not consistent.
20% of heart attack victims do not smoke or suffer from diabetes, high blood pressure, or high levels of cholesterol. For this reason, a new approach to screening cardiovascular pathologies is needed.
Arterial aging, as as measured by the pOpmètre® using Pulse Rate Velocity (PWV), more accurately predicts stroke and heart attack than diabetes, blood pressure or cholesterol combined.
PWV measurements are recommended by the European and French societies of Hypertension and Cardiology. Recognized since last century, this measure was long, tedious and expensive.
Neither ECG or ultrasound serve as screening tools, and coronary CT angiography even less so! In addition, mercury, which served as the basis of diagnosis, is now prohibited.
The pOpmètre® is a breakthrough innovation. This medical device reveals the age of the arteries by measuring Pulse Wave Velocity in 2 minutes.